This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in this journal  Topic Collections  • Critical Care/ Intensive Care Medicine  • Adult Critical Care  • Surgical Physiology, Other  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock

Emad Kandil, MD; Joshua Burack, MD; Ahmed Sawas, MD; Haidy Bibawy, MD; Alex Schwartzman, MD; Michael E. Zenilman, MD; Martin H. Bluth, MD, PhD

Arch Surg. 2008;143(3):242-246.

Background  The importance of cardiomyocyte damage during sepsis has been a recent subject of interest. The progression of sepsis results in the upregulation of proinflammatory cytokines, which act in concert to damage cardiomyocytes and produce cardiac contractile dysfunction. B-type natriuretic peptide (BNP) is a neurohormone released from the ventricles of the heart in response to myocardial dysfunction. The goal of this study was to examine the relationship between BNP levels and the severity of sepsis independent of congestive heart failure.

Design  Prospective, nonrandomized control study.

Setting  University hospital.

Patients  Forty-nine patients were divided into 3 groups: 13 patients with septic shock, 18 with early sepsis, and 18 age-matched healthy control subjects. We excluded patients with septic shock who had comorbid conditions (congestive heart failure or renal failure); sepsis severity was determined using the Sequential Organ Failure Assessment scoring system. Patients with sepsis were followed up for 21 days.

Main Outcome Measures  Serum BNP levels, determined at the time of diagnosis of sepsis and on patient improvement or deterioration.

Results  Patients with septic shock had significantly higher BNP levels on admission compared with the other 2 groups (P < .05). The BNP levels were not significantly elevated in patients with early sepsis. Plasma BNP levels for patients with septic shock were positively correlated with Sequential Organ Failure Assessment scores (r² = 0.74, P < .05) and prognosticated survival.

Conclusions  This study confirms the relationship between BNP level elevation and severity of sepsis independent of congestive heart failure. It also supports the utility of BNP level as a marker for mortality in septic shock.

Author Affiliations: Department of Surgery, State University of New York (SUNY) Downstate Medical Center, Brooklyn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Significance of Circulating B-Type Natriuretic Peptide in Sepsis
Tetsuji Fujita
Arch Surg. 2008;143(10):1021-1022.
EXTRACT | FULL TEXT  

Significance of Circulating B-Type Natriuretic Peptide in Sepsis—Reply
Emad Kandil and Martin H. Bluth
Arch Surg. 2008;143(10):1022-1023.
EXTRACT | FULL TEXT  

RELATED ARTICLE

B-Type Natriuretic Peptide: A Biomarker for the Diagnosis and Risk Stratification of Patients With Septic Shock—Invited Critique
Eddie L. Hoover
Arch Surg. 2008;143(3):246.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Significance of Circulating B-Type Natriuretic Peptide in Sepsis
Fujita
Arch Surg 2008;143:1021-1022.
FULL TEXT